Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-009177

Chief Legal Officer acquired 18,333 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mazzariello Gina Chief Legal Officer 2023-03-16 Grant or award +18,333 55,747 D
Derivatives
Mazzariello Gina Chief Legal Officer 2023-03-16 Grant or award · Stock Option (right to buy) +82,500 82,500 D
Loading xslF345X04/doc4.xml…